https://eyewiretoday.com

Eyewire+Ophthalmic, News, Vision, Alerts, Pipeline, Eye Care, Ophthalmology, Optometry, Cataract, Retina, Cornea, LASIK, Glaucoma, Presbyopia, Myopia, Contact Lenses, Medical Research, Industry, Business, PharmaceuticalGet breaking ophthalmic news, device and drug updates, clinical trial coverage, thought-leader perspective, and industry announcements.Eyewire+ Eyewire headlines are now available as a weekly podcast! Listen Now Eyewire News EyewireTV Podcast Arrow Topics Events Subscribe Menu Search Eyewire News EyewireTV Podcast Arrow Topics Events Subscribe Cataract Refractive Retina Glaucoma Optometry Business Health Care Residents & Fellows Cornea Ophthalmology EyewireTV 09.11.2024 09.11.2024 Watch Episode Watch Episode Zeiss Lenticule Extraction for Hyperopia Alcon Ngenuity 1.5 Oculus Pentacam Cornea OCT Lensar ALLY Adaptive Cataract Treatment System BVI Serenity IOLs Topcon TRK-Omnia Watch Latest Episode Eyewire News 09.17.2024 Alkeus Pharmaceuticals Announces Positive Results from SAGA Study of Gildeuretinol Acetate in GA Patients 09.17.2024 Ripple Therapeutics Partners with AbbVie to Develop Intracameral Implant for Glaucoma 09.17.2024 Atsena Therapeutics Granted FDA Orphan Drug Designation for Gene Therapy Targeting X-linked Retinoschisis View All News View All News Stocks Sort by: Change A-Z AbbVie $193.01 -1.39% Adverum Biotechnologies $7.42 2.91% Alcon $97.32 -1.32% Aldeyra Therapeutics $5.74 -2.88% Alimera Sciences $5.54 0.00% Apellis Pharmaceuticals $35.27 -2.86% Astellas Pharma $12.08 0.58% Bausch + Lomb $18.10 1.69% Bausch Health Companies $7.02 0.21% Bayer $7.47 -0.53% Biogen $197.70 -0.94% Can-Fite Biopharma $2.34 -0.85% Clearside Biomedical $1.30 -0.76% Cooper Companies $109.84 -1.25% Eyenovia $0.51 -4.32% EyePoint Pharmaceuticals $8.76 -0.90% Glaukos $120.49 -3.04% Harrow Health $43.59 -0.86% Hill-Rom $155.96 0.03% Horizon Therapeutics $116.30 0.00% InMed Pharmaceuticals $0.25 0.16% Iridex Corporation $1.91 -4.50% Johnson & Johnson $166.96 -0.02% Kala Pharmaceuticals $5.93 2.86% Kiora Pharmaceuticals $3.46 1.47% Lensar $4.37 2.82% Lineage Cell Therapeutics $0.92 -0.58% MeiraGTx Holdings $4.29 2.02% Merck & Company $118.00 0.03% National Vision Holdings $11.14 3.29% NovaBay Pharmaceuticals $0.51 4.58% Novartis AG Common Stock $115.73 -1.04% Ocugen $1.12 -4.27% Ocugen $1.12 -4.27% Ocular Therapeutix $8.72 -2.35% Oculis $12.00 0.21% Ocuphire Pharma $1.33 2.31% Omeros Corp. $3.99 2.31% Osmotica $1.11 -1.77% Outlook Therapeutics $6.16 3.88% Palatin Technologies $1.36 -2.16% Palatin Technologies $1.36 -2.16% Regeneron $1,141.59 -1.00% Regenxbio $12.88 1.10% Roche $39.21 0.26% Sight Sciences $6.84 0.88% STAAR Surgical Company $32.58 3.82% Takeda Pharmaceutical Company $14.88 0.51% Tarsus Pharmaceuticals $30.70 -3.70% Viatris $11.74 -0.59% View More Stocks View More Stocks Cataract View More Intraoperative Patient Communication During Cataract Surgery Lisa Brothers Arbisser, MD Eyetube Lisa Brothers Arbisser, MD, demonstrates her intraoperative patient communication technique during cataract surgery. Dr. Arbisser highlights the importance of patient interaction to minimize eye movement and optimize surgical precision throughout the procedure. Pseudoexfoliation Zonulopathy: Surgical Approach David Mostafavi, MD Eyetube Cornea Preferred Practice Pattern Updates The latest evidence-based changes and recommendations. Daniel S. Choi, MD Cataract and Refractive Surgery Today Weekly Headlines: First Therapy for Acanthamoeba Keratitis Approved in Europe Eyetube Decreased Vision From Thygeson Superficial Punctate Keratitis Surgeons discuss the disease and their treatment recommendations Karl G. Stonecipher, MD; Jay S. Pepose, MD, PhD; Stephen A. Wexler, MD; and Ronald R. Krueger, MD Cataract and Refractive Surgery Today Strategies for Maximizing Your Time—Your Most Valuable Asset Empower your team, leverage technology, and streamline your workflow to make every moment count. Robert J. Weinstock, MD Cataract and Refractive Surgery Today 09.10.2024 Hilco Vision Appoints Girisha Chandraraj as CEO Eyewire News 09.06.2024 Alcon Unveils SMARTCataract DX and Ngenuity 1.5 at ESCRS Eyewire News 09.05.2024 Medicel Unveils Environmentally Friendly Terralution Range Eyewire News 09.04.2024 Alcon Announces New Cataract Surgery Outcomes Data, Hosts Educational Program at ESCRS Eyewire News View More Refractive View More Breaking Barriers: Women in Femto A Discussion with Zarmeena Vendal, MD, and Durga Larkin, MD Cataract and Refractive Surgery Today Femotosecond laser-assisted cataract surgery (FLACS) has been available to U.S. cataract surgeons since 2011. Zarmeena Vendal, MD, Founder of Westlake Eye Specialists in Austin, Texas, was in practice 6 years when FLACS became available and adopted the technology almost immediately. Durga Larkin, MD, of the Rhode Island Eye Institute in Wakefield, Rhode Island, took much longer to be convinced, but has now adopted FLACS later in her career. Recently, both surgeons spoke about why they adopted LenSx (Alcon) and shared best practices for how to be successful with it. When did you adopt FLACS and what drove you to make that decision? Dr. Vendal: Part of our mission at our practice is to constantly strive to deliver reproducible surgical outcomes. Residing in Austin, Texas, the local culture really values state-of-the-art technology, as do I. When LenSx was first introduced, there was no question that I was interested in exploring it for our practice. Tips for High-Volume Success Maximize your practice’s efficiency with block scheduling, ongoing staff education, and cutting-edge technology. Cathleen M. McCabe, MD Cataract and Refractive Surgery Today Weekly Headlines: Zeiss Lenticule Extraction for Hyperopia Eyetube Mentorship in Ophthalmology Neda Nikpoor, MD; and Neda Shamie, MD Eyetube Decreased Vision From Thygeson Superficial Punctate Keratitis Surgeons discuss the disease and their treatment recommendations Karl G. Stonecipher, MD; Jay S. Pepose, MD, PhD; Stephen A. Wexler, MD; and Ronald R. Krueger, MD Cataract and Refractive Surgery Today Managing Patient Expectations Through Emotional Intelligence Gary Wörtz, MD; and Eric D. Donnenfeld, MD Eyetube 09.10.2024 Hilco Vision Appoints Girisha Chandraraj as CEO Eyewire News 09.06.2024 Alcon Unveils SMARTCataract DX and Ngenuity 1.5 at ESCRS Eyewire News 09.06.2024 Ocuphire Initiates VEGA-3 Phase 3 Trial Evaluating Phentolamine Ophthalmic Solution 0.75% for Presbyopia Eyewire News 09.04.2024 Alcon Announces New Cataract Surgery Outcomes Data, Hosts Educational Program at ESCRS Eyewire News View More Stay Updated Sign up for Eyewire News and EyewireTV e‑newsletters to stay up to date on news in eye care! Subscribe Follow Eyewire News Follow Eyewire News on social media to get the latest updates on news in eye care! Retina View More Perseverance is Key Allen C. Ho, MD, and Robert L. Avery, MD Retina Today It was an exciting summer with the 2024 Olympic Games as a backdrop to our busy clinics. We were tuning in every night after clinic, watching as world records were broken, medals were snagged by unlikely underdogs, and those labeled as the greatest of all time did what they do best. What struck us most this year was the admirable perseverance of many Olympic athletes who shattered the stereotypes of age, race, and gender; battled against injuries; and had the drive to become the first to accomplish what no one else could. We could use a little of that mentality in our clinics, if we are being honest. Not because we aren’t performing at the highest level possible—we are. Rather, it’s because it often feels like we are fighting an uphill battle with some of the patient populations we serve. Some are losing vision no matter what we do. Some of those macular holes just refuse to close. And many patients with diabetes are still walking into the clinic with devastating vision loss that could have been prevented. Annual screening for diabetic retinopathy (DR) is perhaps the easiest way to nip this problem in the bud. Removing an Organic Intraocular Foreign Body Haemoglobin Parida, MBBS, MS Eyetube Weekly Headlines: Rayner Unveils First AI-Designed Spiral IOL Eyetube Weekly Headlines: Zeiss Lenticule Extraction for Hyperopia Eyetube New Retina Radio Journal Club with VBS: Switching to Faricimab in Wet AMD Patients With a History of Anti-VEGF Therapy Eyetube The Value of Multimodal Imaging in the Retina Clinic The utility of simultaneous multimodal image capture illustrated in various disease conditions. Paulo Eduardo Stanga, MD Retina Today 09.17.2024 Alkeus Pharmaceuticals Announces Positive Results from SAGA Study of Gildeuretinol Acetate in GA Patients Eyewire News 09.17.2024 Atsena Therapeutics Granted FDA Orphan Drug Designation for Gene Therapy Targeting X-linked Retinoschisis Eyewire News 09.16.2024 Scientists at Medical College of Georgia Explore New Treatment Target for Diabetic Retinopathy Eyewire News 09.16.2024 New Study on AI-Driven Solutions for Diabetic Eye Disease Testing in Underserved Populations Published Eyewire News View More Glaucoma View More Pearls for Effective Laser Cyclophotocoagulation of the Glaucomatous Eye A discussion of proper transscleral cyclophotocoagulation technique and indications to maximize effectiveness and minimize complications. N. Troy Gurney, MD, and Richard K. Lee, MD, PhD Glaucoma Today Transscleral cyclophotocoagulation (TSCPC) is a laser procedure used to reduce aqueous humor production through ciliary body destruction and thereby lower IOP. With diode laser TSCPC, an 810-nm laser system transmits energy through the sclera to the ciliary body via a handpiece placed along the perilimbal conjunctiva, typically with the patient under retrobulbar or peribulbar anesthesia. Two types of TSCPC are currently in use: continuous and micropulse. This article reviews the use of continuous-wave TSCPC, which we currently find to be more reliable and effective than micropulse CPC.1,2 Traditionally, TSCPC has been used in eyes with low visual potential and elevated IOP refractory to hypotensive agents and in poor candidates for invasive glaucoma surgery. With refinement of the technique, a paradigm shift in glaucoma management has occurred: TSCPC is now performed earlier in treatment algorithms, even as primary therapy,3 and for many types of recalcitrant and advanced glaucoma. We have had excellent results with significant safety and consistency in the treatment of glaucoma that is pseudophakic, aphakic, neovascular, associated with silicone oil after vitrectomy, associated with corneal transplantation, and more.4-8 We believe that TSCPC likely represents the most minimally invasive and versatile surgical glaucoma treatment presently available. TSCPC offers several advantages. The procedure can be performed in the clinic or OR, and treatments are titratable and repeatable. The risk of infection is minimal (no incisions, sutures, etc.) when performed properly to avoid neurotrophic keratitis (see the article section on treatment areas). A fast and comfortable postoperative recovery is also possible. Pressurized Viscodelivery: iTrack Advance Diffuse Blanching I. Paul Singh, MD Eyetube Cyclodialysis Closure Technique I. Paul Singh, MD Eyetube Seen & Heard Glaucoma Today Uveitis and Glaucoma A coordinated multispecialty approach to patient care. Jacob Brubaker, MD; Ahmad A. Aref, MD, MBA; Analisa Arosemena, MD; and Sarju Patel, MD, MPH, MSc Glaucoma Today Schlemm Canal Microstenting Recent updates on MIGS combined with phacoemulsification. Jon Williams, MD, and Manjool Shah, MD Glaucoma Today 09.17.2024 Ripple Therapeutics Partners with AbbVie to Develop Intracameral Implant for Glaucoma Eyewire News 09.11.2024 Iantrek Publishes Clinical Results of Uveoscleral Outflow Technology for Open-Angle Glaucoma Eyewire News 09.11.2024 iCare Launches ST500 Slit-Lamp Based Tonometer Eyewire News 09.10.2024 Hilco Vision Appoints Girisha Chandraraj as CEO Eyewire News View More Featured Podcasts View More Ophthalmology off the Grid Open. Outspoken. It's Ophthalmology off the Grid—an honest look at controversial topics in the field. View Feed New Retina Radio New Retina Radio is a place to hear stories about retina that are told nowhere else. View Feed Eyewire News: The Podcast Get the latest information and breaking news in the ophthalmic field. View Feed View Feed Optometry View More Treating CCH With RF Jackie Garlich, OD, FAAO; Jessilin Quint, OD, MBA, MS, FAAO; Edward H. Jaccoma, MD Eyetube Jackie Garlich, OD, FAAO, and Jessilin Quint, OD, MBA, MS, FAAO, discuss the benefits of using radio frequency to treat conjunctivochalasis (CCH) with Edward H. Jaccoma, MD, an ophthalmologist who specializes in dry eye and ocular aesthetics. Dr. Jaccoma also offers his insights for patient education, managing cases of CCH that don’t go entirely as planned, and more. Let It Snow Although rare, visual snow can have a significant effect on patient quality of life. Grant Sealock, OD, and Osama Said, OD Modern Optometry Key Considerations for Recruiting New Hires Combining human resources and optometry. Marlon Monelyon-Demeritt, OD, MBA, FAAO Modern Optometry Weekly Headlines: First Therapy for Acanthamoeba Keratitis Approved in Europe Eyetube The Changing Landscape of Nutrition in Medicine A look at developments that have propelled us forward and those still to come for eye care. Julie Poteet, OD, MS, CNS, FOWNS Modern Optometry Weekly Headlines: Zeiss Lenticule Extraction for Hyperopia Eyetube 09.16.2024 New Study on AI-Driven Solutions for Diabetic Eye Disease Testing in Underserved Populations Published Eyewire News 09.11.2024 iCare Launches ST500 Slit-Lamp Based Tonometer Eyewire News 09.10.2024 Hilco Vision Appoints Girisha Chandraraj as CEO Eyewire News 09.06.2024 Alcon Unveils SMARTCataract DX and Ngenuity 1.5 at ESCRS Eyewire News View More Business View More Is a Medical Director Right for Your Practice? Take your state scope and practice goals into account when deciding what’s best for you. Hardeep K. Kataria, OD, FAAO Modern Optometry In recent years, there has been increased excitement around ocular aesthetics, and many eye care practitioners have expanded their services to include advanced treatments for dry eye disease (DED) that have origins in aesthetics and dermatology. However, not every state allows aesthetic practice by an optometrist, despite the modality’s FDA approval for DED. Each state has specific laws that may require supervision by a medical director, such as an MD or nurse practitioner, if certain procedures are performed for aesthetic benefit.1 In some states, optometrists cannot perform intense pulsed light (IPL) therapy on the face for facial rosacea, whereas, in other states, they may perform these procedures independent of a medical director. In this article, I will offer some important points to consider, as well as information that was helpful to me on my path to opening my dry eye center. WHY IS OPTOMETRY INTERESTED IN AESTHETICS? IPL therapy targets chromophores such as oxyhemoglobin found in telangiectatic vessels and melanin located in solar lentigines. Radiofrequency, on the other hand, works by targeting water molecules and creating friction to facilitate neocollagenesis and reduce fine lines and wrinkles. This overlap of improvement in the aesthetic appearance of skin and DED symptoms with such treatments is what encompasses ocular aesthetics. Aesthetics can grow more generally from here to include facial and body procedures that are truly only for aesthetic benefit. Given our knowledge and training, optometrists are best poised to discuss adnexal and eyelid anatomy with our patients in a primary care setting. How to Attract the Right Associate Optometrist Keep up with the changing times in optometry with your hiring practices. Christopher Lopez, OD Modern Optometry Navigating Challenges and Embracing Opportunities Selina R. McGee, OD, FAAO; Justin Schweitzer, OD, FAAO; and Walter O. Whitley, OD, MBA, FAAO Modern Optometry Think Outside the Box: Coding For New Retina Drugs Stay updated as guidelines change. Joy Woodke, COE, OCS, OCSR Retina Today Weekly Headlines: Gene Therapies for IRDs Receive FDA Rare Pediatric Disease Designations Eyetube How to Make Better Purchasing Decisions for Your Practice Keep these considerations in mind when deciding what to invest in and what to avoid. Brianna Rhue, OD, FAAO, FSLS Modern Optometry 09.10.2024 Hilco Vision Appoints Girisha Chandraraj as CEO Eyewire News 09.05.2024 Opthea Announces Executive Leadership Changes and Senior Hires Eyewire News 09.04.2024 PulseSight Therapeutics Establishes International Scientific and Clinical Advisory Board Eyewire News 09.03.2024 Samsara Vision Promotes Jason Herod to Chief Commercial Officer Eyewire News View More Diagnostics Iridodialysis Repair Using a Hand-back Technique Ophthalmologists share cases in which this measurement influenced their treatment plans. Carol L. Shields, MD, and Jonathan F. Russell, MD, PhD Retina Today LASIK Iridodialysis Repair Using a Hand-back Technique Ophthalmologists share cases in which this measurement influenced their treatment plans. Carol L. Shields, MD, and Jonathan F. Russell, MD, PhD Retina Today AMD/DME Iridodialysis Repair Using a Hand-back Technique Ophthalmologists share cases in which this measurement influenced their treatment plans. Carol L. Shields, MD, and Jonathan F. Russell, MD, PhD Retina Today Dry Eye Disease Iridodialysis Repair Using a Hand-back Technique Ophthalmologists share cases in which this measurement influenced their treatment plans. Carol L. Shields, MD, and Jonathan F. Russell, MD, PhD Retina Today Gene Therapy Iridodialysis Repair Using a Hand-back Technique Ophthalmologists share cases in which this measurement influenced their treatment plans. Carol L. Shields, MD, and Jonathan F. Russell, MD, PhD Retina Today Keratoplasty Iridodialysis Repair Using a Hand-back Technique Ophthalmologists share cases in which this measurement influenced their treatment plans. Carol L. Shields, MD, and Jonathan F. Russell, MD, PhD Retina Today MIGS Iridodialysis Repair Using a Hand-back Technique Ophthalmologists share cases in which this measurement influenced their treatment plans. Carol L. Shields, MD, and Jonathan F. Russell, MD, PhD Retina Today IOL Selection Iridodialysis Repair Using a Hand-back Technique Ophthalmologists share cases in which this measurement influenced their treatment plans. Carol L. Shields, MD, and Jonathan F. Russell, MD, PhD Retina Today COVID-19 Iridodialysis Repair Using a Hand-back Technique Ophthalmologists share cases in which this measurement influenced their treatment plans. Carol L. Shields, MD, and Jonathan F. Russell, MD, PhD Retina Today About Eyewire+ Eyewire+ keeps readers updated with the latest in the ophthalmic field, featuring breaking news from press releases, medical journals, vision publications, videos, and other news sources. Subscribe to Email Updates Follow Us Eyewire News EyewireTV Podcast Arrow Topics Events Contact Send a Tip About BMC Vision Advertising Subscribe to Email Updates Follow Us © 2024 Bryn Mawr Communications, LLC.All Rights Reserved  •  Privacy Policyenen1726603021https://eyewiretoday.com

แก้ไขไซต์ของคุณ?

คุณกำลังทำอะไร?